Neil Baksh was doing everything right. He was eating the right things. He wasn’t smoking. He was exercising six days a week. So he was shocked when he was diagnosed with prostate cancer.
Equally surprising was that he had symptoms at all, and they weren’t even symptoms of prostate cancer, which is usually symptomless. They pointed to a problem with his bladder and an enlarged prostate; the latter is common in older men and usually benign. But not this time.
Neil was only fifty-six and doing fine until, on a Christmas trip to Toronto in 2012, he was unable to discharge urine. As a nurse, Neil is very open about his story, and he wants to help raise awareness. “I had the urge to pee on the whole eight-hour trip but couldn’t. It was extremely uncomfortable.” More
From 2006 to 2010, prostate cancer accounted for the largest number (9,690) and the greatest percentage (25.4) of all invasive cancers diagnosed among men in Pennsylvania. Very troubling was the fact that the age-adjusted rate of prostate cancer among African-American men was 60 percent higher and the death rate was twice that of white men, with nearly one out of every six cases diagnosed at a late stage.
These data reinforce the need for health care providers, health systems and insurance carriers to reach a consensus on the value of prostate cancer testing and send a clear message to all men (particularly those with a family history or of African-American descent). The current situation is utterly confusing and stressful. More
By Dr. Scott Owens
As a practicing urologist for the last 18 years focused on treating men with prostate cancer, I was alarmed by the final recommendation of the U.S. Preventive Services Task Force that healthy men should no longer receive prostate specific antigen testing.
Prostate cancer screenings are still key to early detection.
What is truly shocking is that this recommendation was made without a single urologist or oncologist serving on the task force. Had the task force bothered to have a specialist in the field, it might have seen the study published this spring in the New England Journal of Medicine that once again reaffirmed that prostate screening saves lives. More
By Dr. Fred Newton, Prostate Cancer Center,
An integral component of Urology of Central PA
as printed in 50plus Senior News September 2009
Should you test for prostate cancer or shouldn’t you? No doubt you’ve read or heard about recent studies questioning the advisability of PSA screening for prostate cancer.
In brief, some researchers are concerned that prostate cancer can be so slow growing that the prescribed treatment and side effects are often worse than the potential consequences of inaction.
However, should routine PSA testing be discouraged, one very perplexing dilemma remains: How can any unsuspecting patient know for certain if he harbors cancer cells, and if so, whether his particular cancer is slow growing or of the more aggressive type that can quickly become fatal if left untreated? More